David Shieh, MD
Retina Specialist · Beachwood, OHNPI 1740741701
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,473 of the $2,862 with a category attached, or 86.4%. 15 manufacturers reported payments, led by Alcon at 33.3% of the total. That places this record below the midpoint for retina specialist clinicians in OH, where the typical reported total is $4,390.
Across 42 payments — averaging $68.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$953
- Bausch & Lomb Americas Inc.$374
- Apellis Pharmaceuticals, Inc.$296
- AbbVie$274
- Glaukos Corporation$263
- Genentech USA, Inc.$242
- plus $460 from 9 others
What the payments were for
- Travel & lodging$28910%
- Food & beverage$2,47386%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 8 | $953 |
| Bausch & Lomb Americas Inc. | 4 | $374 |
| Apellis Pharmaceuticals, Inc. | 4 | $296 |
| AbbVie(2 entities) | 4 | $274 |
| Glaukos Corporation | 4 | $263 |
| Genentech USA, Inc. | 5 | $242 |
| Regeneron | 1 | $125 |
| Ivantis, Inc | 1 | $121 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| ANI Pharmaceuticals, Inc. | 2 | $34 |
| Oyster Point Pharma, Inc. | 1 | $26 |
| Amgen | 1 | $24 |
| Neurotech Pharmaceuticals, Inc. | 1 | $21 |
| Harrow Eye, LLC | 1 | $19 |
| NEW World Medical,inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AcrySof IQ VIVITY$278
- STELLARIS$229
- Constellation$188
- Erivedge$138
- Syfovre$129
- EYLEA$125
- OZURDEX$125
- Hydrus Microstent$121
- iStent inject W$101
How this compares
$2,862 in reported general payments places this provider in the 45th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 23 | $943 |
| Brimonidine Tartrate | 12 | $239 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $180 |
| Latanoprost | 12 | $79 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Beachwood
- Joseph ConeyBeachwood$980K
- David MillerBeachwood$299K
- Michael NovakBeachwood$71K
- Scott PendergastBeachwood$66K
- Llewelyn RaoBeachwood$58K
- Jerome SchartmanBeachwood$30K
- Sean PlattBeachwood$23K
- Lediana GoduniBeachwood$9K
- Shawn LewisBeachwood$7K
- Hernando ZegarraBeachwood$478
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.